Iclusig 15mg and 45mg film-coated tablets
Last Updated on eMC 09-Feb-2017 View document | Incyte Biosciences UK Ltd Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 09-Feb-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
Updated on 06-Dec-2016 and displayed until 09-Feb-2017
Reasons for adding or updating:
- Change to section 6 - manufacturer
Updated on 24-Nov-2016 and displayed until 06-Dec-2016
Reasons for adding or updating:
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 01-Sep-2016 and displayed until 24-Nov-2016
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 30-Sep-2015 and displayed until 01-Sep-2016
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 04-Aug-2015 and displayed until 30-Sep-2015
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Incyte Biosciences UK Ltd
Riverbridge House, Guildford Road, Leatherhead, Surrey, KT22 9AD, UK
+44 800 2798535
+44 1372 365900
00800 000 274 23
+44 800 7833711
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue